Increased levels of nuclear factor KB and fos-related antigen 1 in lung tissues from patients with acute respiratory distress syndrome

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 5, 2011, Pages 647-654

  Fudala, Rafal ^a   Allen, Timothy Craig ^b   Krupa, Agnieszka ^a   Cagle, Philip T ^c   Nash, Sandra ^b   Gryczynski, Zygmunt ^d   Gryczynski, Ignacy ^d   Kurdowska, Anna K ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR FRA 1;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LUNG; METABOLISM; METHODOLOGY; PATHOLOGY;

BIOLOGICAL MARKERS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUNG; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 79956304239     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tsushima K, King LS, Aggarwal NR, De Gorordo A, D'Alessio FR, Kubo K. Acute lung injury review. Intern Med. 2009;48(9):621-630.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18): 1334-1346.
3. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27(4):337-349. (Pubitemid 44272603)
4. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369(9572): 1553-1565.
5. Wright JL. Adult respiratory distress syndrome. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. 3rd ed. New York, NY: Theime; 2005:355-370.
6. Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc. 2006;81(2):205-212. (Pubitemid 43205775)
7. Cheng D, Han W, Chen SM, et al. Airway epithelium controls lung inflammation and injury through the NF-KB pathway. J Immunol. 2007,178(10): 6504-6513. (Pubitemid 46717434)
8. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor- κB in pulmonary diseases. Chest. 2000; 117(5):1482-1487. (Pubitemid 30321607)
9. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2001 ;281 (5) 1037-1050.
10. Mossman BT, Lounsbury KM, Reddy SP. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol. 2006;34(6):666-669. (Pubitemid 43825330)
11. Schwartz MD, Moore EE, Moore FA, et al. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996;24(8):1285-1292. (Pubitemid 26262400)
12. Sitoh H, Masuda T, Zhang XY, Shimura S, Shirato K. Effect of antisense oligonucleotides to nuclear factor-κB on the survival of LPS-induced ARDS in mouse. Exp Lung Res. 2002;28(3):219-231. (Pubitemid 34235062)
13. Zhai R, Zhou W, Gong MN, et al. Inhibitor κB -α haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med. 2007;35(3):893-898. (Pubitemid 46407807)
14. Adamzik M, Frey UH, Rieman K, et al. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med. 2007;33(7) 1199-1203.
15. von Bismarck P, Klemm K, Wistàdt C-FG, Winoto-Morbach S, Schütze S, Krause MF. Selective NF-KB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model. Pulm Pharmacol Ther. 2009;22(4):297-304.
16. Mukhopadhyay S, Mukherjee S, Smith M, Das SK. Activation of MAPK/AP1 signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard gas analog. Toxicol Lett. 2008:181(2) 112-117.
17. Mukhopadhyay S, Mukherjee S, Stone WL, Smith M, Das SK. Role of MAPK/AP-1 signaling pathway in the protection of CESS-induced lung by antioxidant liposome. Toxicology. 2009;261(3):143-151.
18. Allen TC, Fudala R, Nash SE, Kurdowska A. Anti-interleukin 8 autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung: colocalization with FcγRlla in lung tissue from acute respiratory distress syndrome patients. Arch Pathol Lab Med. 2007;131(3):452-456. (Pubitemid 46365528)
19. Nardone LL, Andrews SB. Cell line A549 as a model of type II pneumocyte: phospholipid biosynthesis from native and organometallic precursors. Biochim BiophysActa. 1979;573(2):276-295. (Pubitemid 9175709)
20. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243(2):359-366. (Pubitemid 28488846)
21. Ye SF, Wu YH, Hou ZQ, Zhang QQ. ROS and NF-kappaB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. Biochem Biophys Res Commun. 2009;379(2):643-648.
22. Phelps DS, Floros J. Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization. Exp Lung Res. 1991; 17(6):985-995.
23. Shyu YJ, Suarez CD, Hu CD. Visualization of AP-1 NF-kappaB ternary complexes in living cells by using a BiFC-based FRET. Proc Natl Acad Sci USA. 2008 105(1):151-156.
24. Yang KY, Arcaroli JJ, Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med. 2003 167(12)1567-1574.
25. Coldren CD, Nick JA, Poch KR, et al. Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol. 2006;291(6):1267-1276.
26. Shen HM, Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 2009; 14(4): 348-363.
27. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446(7135):557-561. (Pubitemid 46514732)
28. Takada Y, Ray N, Ikeda E, et al. Fos proteins suppress dextran sulfate sodium-induced colitis through inhibition of NF-kappaB. J Immunol. 2010; 184(2):1014-1021.